Strategic Analysis of the World Clinical Development Pipelines in the Pharmaceutical Industry

Strategic Analysis of the World Clinical Development Pipelines in the Pharmaceutical Industry

 

RELEASE DATE
28-Jan-2005
REGION
Global
Research Code: F238-01-00-00-00
SKU: HC01433-GL-MR_05896
$4,950.00
In stock
SKU
HC01433-GL-MR_05896
$4,950.00
DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This strategic analysis service provides detailed analysis of world clinical development pipelines, focusing on the top ten global pharmaceutical manufacturers. The service in powerpoint format (approximately 161 slides) focuses not just only on overall market revenues and competitor analysis but also on strategies for achieving success in this established market and the overall costs of putting a drug through the clinical development process.

Table of Contents

Overview

  • Overview

Research Scope & Methodology

  • Research Scope & Methodology

Introduction & Background

  • Introduction & Background
  • Glossary
  • Abbreviations

Pharmaceutical Industry Dynamics

  • Pharmaceutical Market Dynamics
  • Key Market Trends
  • Major Challenges for the Pharmaceutical Industry
  • Market Drivers
  • Market Restraints
  • Overall State of the Market
  • Forecast Assumptions
  • Market Engineering Measurements
  • Total Market Revenue Forecast
  • Market Analysis
  • Top Ten Pharmaceutical Companies by Revenue
  • Market Share Analysis

Clinical Development Cost Dynamics

  • Clinical Development Cost Dynamics
  • Phases of the Clinical Trials Process
  • Testing Procedures Used in Clinical Trials
  • Assumptions in Estimating Cost of Clinical Trials
  • Changes in Clinical Trials (1980-2003)
  • Mean Clinical Trial Costs
  • Clinical Trial Phase Length
  • Clinical Trial Costs by Disease Indication
  • Clinical Trials in North America Compared to Europe
  • Clinical Trials in Europe: East Versus West
  • Summary of Trends
  • Future Trends in Clinical Trials

Research Trends & Pipelines of Top Ten Pharmaceutical Companies

  • Research Trends & Pipelines of Top Ten Pharmaceutical Companies
  • Assumptions in Pipeline Analysis
  • Overall Industry Research Trends
  • Pipeline Analysis - Pfizer Inc
  • Pipeline Analysis - Johnson & Johnson Inc
  • Pipeline Analysis - GlaxoSmithKline Plc
  • Pipeline Analysis - Sanofi-Aventis Group
  • Pipeline Analysis - Novartis AG
  • Pipeline Analysis - F. Hoffman-La Roche Ltd
  • Pipeline Analysis - Merck & Co. Inc
  • Pipeline Analysis - Bristol-Myers Squibb Company
  • Pipeline Analysis - Abbott Laboratories
  • Pipeline Analysis - AstraZeneca Plc

Strategic Analysis & Recommendations

  • Strategic Analysis & Recommendations
  • Major Challenges & Strategic Proposals
  • Research Priority Forecast
  • Strategic Anticipation
  • Market Maturation Process
  • Competitive Framework
  • Potential Threats
  • Meeting the Challenge

Frost & Sullivan Awards

  • Frost & Sullivan Awards
  • Growth Strategy Leadership Award
  • Market Leadership Award
  • Product Differentiation Innovation Award

World Clinical Approvals (2000-2004)

  • World Clinical Approvals (2000-2004)
  • New Drugs Approved by the FDA (2000-2004)
  • New Drugs Approved by the EMEA (2000-2004)

Decision Support Databases

  • Decision Support Databases
  • Number of Biotechnology Companies - Western Europe and North America (1999-2006)
  • Biotechnology European Patents Filed (1996-2000)
  • Governmental Research and Development Investment in Biotechnology (1999-2006)
  • Pharmaceutical Research and Development Expenditure (1999-2006)

Frost & Sullivan

  • Frost & Sullivan
  • Healthcare Team
  • Our Capabilities